Duncan Williams Asset Management, LLC
Source: SEC Form 13F · as of Mar 2026Duncan Williams Asset Management, LLC holds 15 biotech & pharma companies tracked by BioSniper, totaling $10.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$10.5M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 6,214 | $1.5M |
| LLYELI LILLY & Co | 1,275 | $1.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,161 | $1.1M |
| ABBVAbbVie Inc. | 4,993 | $1.1M |
| AMGNAMGEN INC | 2,632 | $926K |
| MRKMerck & Co., Inc. | 7,052 | $848K |
| APLSApellis Pharmaceuticals, Inc. | 17,005 | $684K |
| PRTAPROTHENA CORP PUBLIC LTD CO | 70,281 | $683K |
| ZYMEZymeworks Inc. | 22,095 | $553K |
| ABTABBOTT LABORATORIES | 4,464 | $458K |
| BMYBRISTOL MYERS SQUIBB CO | 7,110 | $431K |
| ANABANAPTYSBIO, INC | 6,525 | $362K |
| PFEPFIZER INC | 10,448 | $293K |
| PMPhilip Morris International Inc | 1,511 | $250K |
| RLAYRelay Therapeutics, Inc. | 11,438 | $114K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.